Todd Watanabe

Executive · Arcutis Biotherapeutics, Inc.

Rank #3,737 SEC EDGAR (United States) ↗ Files from United States

Details

Officer and board memberPharmaceuticals & BiotechnologyARQTSEC CIK 0001801061

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$23.1M
1-day change
▲ 1.01%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$16.6M – $30.2M2026-09-04

Insider activity May 2, 2024 – Mar 2, 2026

Todd Watanabe is recorded in filings to the U.S. SEC via EDGAR as officer and board member, and reported 33 transactions between May 2, 2024 and Mar 2, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$21.3K
2 purchases on file priced rows only
Open-market sales (code S)
$6.91M
25 sales on file priced rows only
All reported transactions
33
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Todd Watanabe sold 48,945 Arcutis Biotherapeutics, Inc. (ARQT) shares for $1,485,970 on Nov 24, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Todd Watanabe sold 48,945 Arcutis Biotherapeutics, Inc. (ARQT) shares for $1,485,970 on Nov 24, 2025
Date Insider Transaction Shares Price Value Filing
Nov 24, 2025 Todd Watanabe S Open-market sale 48,945 held after: 740,537 $30.36 $1,485,970 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

3 insiders bought Arcutis Biotherapeutics, Inc. (ARQT) shares worth $34,043 on Nov 30, 2024

Cluster buying

3 different insiders made 3 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought Arcutis Biotherapeutics, Inc. (ARQT) shares worth $34,043 on Nov 30, 2024
Date Insider Transaction Shares Price Value Filing
Nov 30, 2024 Masaru Matsuda P Open-market purchase 1,657 held after: 187,030 $7.11 $11,781 SEC filing ↗
Nov 30, 2024 Todd Watanabe P Open-market purchase 2,038 held after: 838,430 $7.11 $14,490 SEC filing ↗
Nov 30, 2024 Larry Todd Edwards P Open-market purchase 1,093 held after: 137,728 $7.11 $7,771 SEC filing ↗

Total of the rows above: $34,043, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 20 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 34 on file in total. See the full history on EDGAR ↗

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 4,375 shares $114.3K at $26.12 SEC filing ↗
  2. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 3,172 shares $74.9K at $23.61 SEC filing ↗
  3. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale × 2 37,349 shares $940.5K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    36,281 $25.16 $912.8K SEC filing ↗
    1,068 $25.91 $27.7K SEC filing ↗
  4. Arcutis Biotherapeutics, Inc. ARQT A Grant or awardnot a buy/sell decisionreported at zero 102,000 shares $0 at $0.00 SEC filing ↗
  5. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 19,833 shares $505.7K at $25.50 SEC filing ↗
  6. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 48,945 shares $1.49M at $30.36 SEC filing ↗
  7. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 1,055 shares $31.7K at $30.00 SEC filing ↗
  8. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale × 2 11,547 shares $285.4K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    69 $25.40 $1.8K SEC filing ↗
    11,478 $24.71 $283.6K SEC filing ↗
  9. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 40,000 shares $1.00M at $25.03 SEC filing ↗
  10. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 20,739 shares $415.6K at $20.04 SEC filing ↗
  11. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale × 2 24,261 shares $469.1K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    9,261 $20.02 $185.4K SEC filing ↗
    15,000 $18.91 $283.7K SEC filing ↗
  12. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 504 shares $8.8K at $17.52 SEC filing ↗
  13. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 9,625 shares $168.8K at $17.54 SEC filing ↗
  14. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 11,547 shares $165.5K at $14.33 SEC filing ↗
  15. Arcutis Biotherapeutics, Inc. ARQT G Bona fide gift × 3not a buy/sell decisionreported at zero 2,991 shares $0
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    997 $0.00reported at zero $0 SEC filing ↗
    997 $0.00reported at zero $0 SEC filing ↗
    997 $0.00reported at zero $0 SEC filing ↗
  16. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 11,448 shares $173.9K at $15.19 SEC filing ↗
  17. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 2,171 shares $38.1K at $17.56 SEC filing ↗
  18. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 1,500 shares $26.3K at $17.52 SEC filing ↗
  19. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 1,200 shares $21.1K at $17.61 SEC filing ↗
  20. Arcutis Biotherapeutics, Inc. ARQT S Open-market sale 4,135 shares $54.9K at $13.28 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
Arcutis Biotherapeutics, Inc. ARQT Common Stock 968,271 $23.90 $23.1M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Todd Watanabe reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.